When do you notice Wegovy working — and what does 'working' actually look like?

The first injection: you won't feel nothing, but probably not what you pictured

Picture this: you've given yourself your first 0.25mg dose on a Sunday evening, and by Monday morning you're half-expecting to feel different. You might. The change that catches most people off guard isn't the number on the scales, it's a quieter relationship with food. A question our prescribers hear most weeks is some version of "is this even doing anything?" because the early signal isn't dramatic weight loss. It's subtler: a meal that fills you up faster than usual, or noticing you didn't finish what's on your plate without consciously trying.

That's because semaglutide's first job is hormonal, not mechanical. It activates GLP-1 receptors, pathways involved in signalling fullness and regulating how quickly food leaves your stomach. Those shifts happen quickly at a biological level. Whether you consciously register them in week one depends on how sensitive you are and how high your usual appetite was before starting. Some people feel the change within days; others need two or three weeks at the starter dose, and if you're wondering when Wegovy will start working for your particular situation, the answer genuinely varies from person to person. Neither pattern is wrong.

Nausea is the most commonly reported early side effect, and it tends to be most noticeable right after an injection, particularly in the first few days of a new dose. It generally eases as your body adjusts. The NHS semaglutide medicines page lists the common GI side effects clearly, worth bookmarking for those first few weeks.

Weeks four to twelve: when weight loss usually begins in earnest

By the time you reach your second or third dose (still at 0.25mg or moving to 0.5mg under your prescriber's guidance), most people start seeing the scale move. Slowly at first, often one to two pounds per week on average, sometimes less. That pace is normal, and frankly it's healthy. Rapid early losses can mean water weight more than fat, and the steadier the loss, the more likely it reflects genuine body-composition change.

If you started treatment around payday or just before a holiday, don't use a short, disrupted window as your baseline. Timing and life context genuinely affect what you notice in those first weeks, so it helps to understand when Wegovy starts working in a typical treatment timeline before drawing conclusions. Give it a full injection cycle before making any judgements.

Around the eight to twelve week mark, many people report a more settled experience: the nausea (if they had it) has largely passed, appetite is reliably reduced, and weight loss has become more consistent. This is also when dose titration may begin, moving up through the schedule toward the 2.4mg maintenance dose. Each step up can bring a brief return of GI symptoms, which typically settle again within a week or two. For a closer look at how the early phase tends to unfold, the feelings in those first weeks page covers the subjective experience in more detail.

Three to six months: where meaningful results become visible

Clinical trial data gives us the clearest picture of what sustained Wegovy treatment can achieve. In the STEP 1 trial, published in the New England Journal of Medicine, adults taking semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks. That's an average, some participants lost considerably more, others less. The trajectory wasn't linear either: the rate of loss typically slows as you approach your new set point.

By the three to six month window most people are on or near their maintenance dose and seeing their clearest results so far. This is also the checkpoint that NICE guidance references: if weight loss hasn't reached 5% after six months at the highest tolerated dose, continuing treatment is formally reviewed. That threshold exists to ensure the medicine is genuinely working for you, not as a pass/fail judgment. You can read more about the clinical evidence underpinning Wegovy on the Wegovy overview page, which covers the broader picture of how semaglutide is used for weight management in the UK.

If you're weighing up the cost of private treatment alongside what you're noticing clinically, the Wegovy cost context page explains what private pricing typically includes, worth reading if you're planning ahead beyond the first few months.

When to expect a plateau, and when to talk to your prescriber

A weight-loss plateau at some point during treatment is normal. Your body adapts to a lower calorie intake, metabolism adjusts, and progress slows. This isn't failure; it's physiology. The question is whether it's a temporary plateau or a sign that the current dose isn't the right fit, and reading about when Wegovy started working for others in similar circumstances can help you calibrate what's reasonable to expect at each stage. That's exactly the kind of question your prescriber is there to work through with you, it's not something to try to resolve alone by skipping doses or changing the schedule.

There are also signals that warrant prompt medical attention rather than waiting for your next review: severe, persistent stomach pain that radiates toward the back needs to be assessed urgently, given the known (though infrequent) association between GLP-1 medicines and pancreatitis, as the MHRA highlighted in its Drug Safety Update communications. Suspected side effects can also be reported through the Yellow Card scheme. For anything routine (questions about what you're noticing, whether it's on schedule, what comes next) our clinical team at nume provides aftercare seven days a week, so there's always someone qualified to ask. When you're ready to explore whether Wegovy is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your case the same day.